Search research articles
Contact Us
Filters
Showing results (141-150 of 150) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 150 results.
Current Treatment Options in Oncology
|
December 31, 2003
Salivary gland neoplasms
Terry A Day, John Deveikis, M Boyd Gillespie, et al.
The Laryngoscope
|
August 25, 2020
Free Flap Inset Techniques in Salvage Laryngopharyngectomy Repair: Impact on Fistula Formation and Function
Diane W Chen, Mark A Ellis, Peter Horwich, et al.
Head & Neck
|
April 19, 2022
Safety of microvascular free tissue transfer reconstruction of the head and neck in the setting of chronic pharmacologic immunosuppression
Ray Wang, Peter Horwich, Vlad C Sandulache, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 3, 2006
Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo
Can E Senkal, Suriyan Ponnusamy, Michael J Rossi, et al.
Current Treatment Options in Oncology
|
January 15, 2003
Oral cancer treatment
Terry A Day, Betsy K Davis, M Boyd Gillespie, et al.
JCO Oncology Practice
|
August 28, 2020
Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer
Evan M Graboyes, Chanita Hughes Halbert, Hong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 28, 2011
Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response
Sahar A Saddoughi, Elizabeth Garrett-Mayer, Uzair Chaudhary, et al.
JCO Oncology Practice
|
March 10, 2021
Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer
Evan M Graboyes, Katherine R Sterba, Hong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2018
Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial
Terry A Day, Keisuke Shirai, Paul E O'Brien, et al.
Cell Reports. Medicine
|
November 10, 2021
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma
Hannah M Knochelmann, Joshua D Horton, Sixue Liu, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 150) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 150 results.
Current Treatment Options in Oncology
|
December 31, 2003
Salivary gland neoplasms
Terry A Day, John Deveikis, M Boyd Gillespie, et al.
The Laryngoscope
|
August 25, 2020
Free Flap Inset Techniques in Salvage Laryngopharyngectomy Repair: Impact on Fistula Formation and Function
Diane W Chen, Mark A Ellis, Peter Horwich, et al.
Head & Neck
|
April 19, 2022
Safety of microvascular free tissue transfer reconstruction of the head and neck in the setting of chronic pharmacologic immunosuppression
Ray Wang, Peter Horwich, Vlad C Sandulache, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 3, 2006
Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo
Can E Senkal, Suriyan Ponnusamy, Michael J Rossi, et al.
Current Treatment Options in Oncology
|
January 15, 2003
Oral cancer treatment
Terry A Day, Betsy K Davis, M Boyd Gillespie, et al.
JCO Oncology Practice
|
August 28, 2020
Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer
Evan M Graboyes, Chanita Hughes Halbert, Hong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 28, 2011
Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response
Sahar A Saddoughi, Elizabeth Garrett-Mayer, Uzair Chaudhary, et al.
JCO Oncology Practice
|
March 10, 2021
Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer
Evan M Graboyes, Katherine R Sterba, Hong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2018
Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial
Terry A Day, Keisuke Shirai, Paul E O'Brien, et al.
Cell Reports. Medicine
|
November 10, 2021
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma
Hannah M Knochelmann, Joshua D Horton, Sixue Liu, et al.
Page
of 15